Brief: Cue Biopharma Reports First Quarter 2022 Financial Results
10/05/2022 22:34
May 10 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
* CUE BIOPHARMA - REPORTED COLLABORATION REVENUE OF ABOUT
$1.0
MILLION AND $1.6 MILLION FOR THREE MONTHS ENDED MARCH 31, 2022
AND 2021, RESPECTIVELY
* CUE BIOPHARMA INC QTRLY NET LOSS PER COMMON SHARE - BASIC
AND
DILUTED$0.44
Source text for Eikon: ID:nGNX93wMkh
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria